Repurposing riluzole as an anti-osteosarcoma agent
Frontiers - 05 May 2025Repurposing riluzole as an anti-osteosarcoma agent ...
osteosarcoma
Repurposing riluzole as an anti-osteosarcoma agent ...
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma - Oncogene
Nature - 11 Dec 2024Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma - Oncogene ...
Unmasking Nrf2 as a key driver of treatment resistance in osteosarcoma
News-Medical - 20 Apr 2025Unmasking Nrf2 as a key driver of treatment resistance in osteosarcoma ...
Bone cancer - Symptoms and causes
Mayo Clinic - 05 Dec 2024Bone cancer - Symptoms and causes ...
KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1
Nature - 12 Apr 2025KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1 ...
Pioneering research identifies three subtypes of osteosarcoma for better treatment
News-Medical - 20 Dec 2024Pioneering research identifies three subtypes of osteosarcoma for better treatment ...
An analysis of extraskeletal osteosarcoma based on the literature
Nature - 06 Jan 2025An analysis of extraskeletal osteosarcoma based on the literature ...
Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells
Nature - 07 Apr 2025Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells ...
Family reflections: a legacy of hope: advancing research for osteosarcoma in memory of Zach Sobiech
Nature - 09 Apr 2025Family reflections: a legacy of hope: advancing research for osteosarcoma in memory of Zach Sobiech ...
Improved gated recurrent unit-based osteosarcoma prediction on histology images: a meta-heuristic-oriented optimization concept
Nature - 01 Apr 2025Improved gated recurrent unit-based osteosarcoma prediction on histology images: a meta-heuristic-oriented optimization concept ...
Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma
Nature - 27 Feb 2025Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma ...
Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening
Nature - 17 Mar 2025Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening ...
Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma
Nature - 24 Feb 2025Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma ...
Single-cell and spatial transcriptomics reveals the key role of MCAM
Nature - 13 Apr 2025Single-cell and spatial transcriptomics reveals the key role of MCAM ...
Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis
Nature - 24 Mar 2025Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis ...
Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis
Nature - 17 Jan 2025Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis ...
Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
Nature - 02 Jan 2025Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity ...
Long noncoding RNA DHRS4 antisense RNA 1 suppresses osteosarcoma cell proliferation and promotes apoptosis through a competitive endogenous RNA mechanism
Nature - 23 Jan 2025Long noncoding RNA DHRS4 antisense RNA 1 suppresses osteosarcoma cell proliferation and promotes apoptosis through a competitive endogenous RNA mechanism ...
Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma | Oncogene
Nature - 19 Nov 2024Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma | Oncogene ...